Playbook – Unlocking value: Addressing benefits, AI, investment and workforce challenges

Healthcare is no longer just a once-a-year benefits renewal issue—it’s becoming a CFO-grade risk that can disrupt forecasts, force trade-offs, and limit investment in wages, growth, and workforce transformation.

Emerging cost accelerants, especially pharmaceuticals, are a growing concern for CFOs.

47% of CFOs cited GLP-1 drugs as very concerning or significantly concerning because adoption can expand quickly, shift spend mid-year and materially change pharmacy cost with uncertain near-term offsets. GLP-1s may improve long-term health, but their rapidly rising costs can outpace budgets and planning.

Our new playbook brings together research and practical frameworks to help leaders understand what’s driving cost pressure and take six strategic actions. Learn how to build a more active operating rhythm—with tighter monitoring, scenario modeling, and more frequent reforecasting— so you can manage people spend like a portfolio, reduce volatility, and protect the employee experience while avoiding downstream costs.

Please fill out the form below to receive your playbook.

First Name(Required)

Last Name(Required)

Job Title(Required)

Company(Required)

Address(Required)

Address 1 City State ZIP

Country(Required)

Phone(Required)

Email(Required)

Job Level

Job Function

Employee Size

Annual Revenue

Employee Benefit News (EBN) is the primary media resource for decision makers in the worlds of employee benefits, human resources and workplace culture. As the dynamics of these spaces continue to shift and become increasingly complex, EBN delivers expert insights to allow business leaders to navigate their industries with agility. From helping benefits managers meet the challenges of reducing care costs and improving retirement plans to providing HR leaders with guidance on building a talented and diverse workforce, EBN drives the conversation and delivers the research and analysis to help readers support their companies’ objectives.

By submitting this form, I acknowledge that I have read and understand Arizent’s Privacy Policy.

Contact information is shared with sponsors. By downloading the asset, you agree to allow your information to be shared with this sponsor.